These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2130687)

  • 1. Pancreatic calcifications in cystic fibrosis (CF).
    Mariano A; Paolo C; Maurizio M; Serena D
    Acta Univ Carol Med (Praha); 1990; 36(1-4):171-3. PubMed ID: 2130687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
    De Boeck K; Weren M; Proesmans M; Kerem E
    Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency.
    Stern RC; Eisenberg JD; Wagener JS; Ahrens R; Rock M; doPico G; Orenstein DM
    Am J Gastroenterol; 2000 Aug; 95(8):1932-8. PubMed ID: 10950038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [On mucoviscidosis (pancreatic cystic fibrosis)].
    Koch E
    Z Allgemeinmed; 1964 Dec; 40(35):1499-503. PubMed ID: 5889477
    [No Abstract]   [Full Text] [Related]  

  • 5. Pancreas and cystic fibrosis: the implications of increased survival in cystic fibrosis.
    Krysa J; Steger A
    Pancreatology; 2007; 7(5-6):447-50. PubMed ID: 17912009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cimetidine and pancreatic enzymes on serum and fecal bile acids and fat absorption in cystic fibrosis.
    Boyle BJ; Long WB; Balistreri WF; Widzer SJ; Huang N
    Gastroenterology; 1980 May; 78(5 Pt 1):950-3. PubMed ID: 7380201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic polypeptide in cystic fibrosis.
    Nousia-Arvanitakis S; Tomita T; Desai N; Kimmel JR
    Arch Pathol Lab Med; 1985 Aug; 109(8):722-6. PubMed ID: 3893382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcification of the pancreas in cystic fibrosis.
    Iannaccone G; Antonelli M
    Pediatr Radiol; 1980 Feb; 9(2):85-9. PubMed ID: 7367064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired gastric myolectrical activity in patients with cystic fibrosis.
    Bentur L; Hino B; Shamir R; Elias N; Hartman C; Eshach-Adiv O; Berkowitz D
    J Cyst Fibros; 2006 Aug; 5(3):187-91. PubMed ID: 16627012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis.
    Durno C; Corey M; Zielenski J; Tullis E; Tsui LC; Durie P
    Gastroenterology; 2002 Dec; 123(6):1857-64. PubMed ID: 12454843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The changing face of the exocrine pancreas in cystic fibrosis: the correlation between pancreatic status, pancreatitis and cystic fibrosis genotype.
    Augarten A; Ben Tov A; Madgar I; Barak A; Akons H; Laufer J; Efrati O; Aviram M; Bentur L; Blau H; Paret G; Wilschanski M; Kerem BS; Yahav Y
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):164-8. PubMed ID: 18301294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relation between gene mutations and pancreatic exocrine function in patients with cystic fibrosis].
    Radivojević D; Guć-Sćekić M; Djurisić M; Lalić T; Minić P; Kanavakis E
    Srp Arh Celok Lek; 2001; 129 Suppl 1():6-9. PubMed ID: 15637983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis.
    Colombo C; Battezzati PM; Podda M; Bettinardi N; Giunta A
    Hepatology; 1996 Jun; 23(6):1484-90. PubMed ID: 8675168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study.
    Brady MS; Garson JL; Krug SK; Kaul A; Rickard KA; Caffrey HH; Fineberg N; Balistreri WF; Stevens JC
    J Am Diet Assoc; 2006 Aug; 106(8):1181-6. PubMed ID: 16863712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Faecal elastase-1 and fat-soluble vitamin profiles in patients with cystic fibrosis in Western Norway.
    Dorlöchter L; Aksnes L; Fluge G
    Eur J Nutr; 2002 Aug; 41(4):148-52. PubMed ID: 12242582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The steatocrit: a simple method for monitoring fat malabsorption in patients with cystic fibrosis.
    Colombo C; Maiavacca R; Ronchi M; Consalvo E; Amoretti M; Giunta A
    J Pediatr Gastroenterol Nutr; 1987; 6(6):926-30. PubMed ID: 3681578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrase MT12 and Ultrase MT20 in the treatment of exocrine pancreatic insufficiency in cystic fibrosis: safety and efficacy.
    Konstan MW; Stern RC; Trout JR; Sherman JM; Eigen H; Wagener JS; Duggan C; Wohl ME; Colin P
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1365-71. PubMed ID: 15606399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mild to moderate cystic fibrosis is not associated with increased fracture risk in children and adolescents.
    Rovner AJ; Zemel BS; Leonard MB; Schall JI; Stallings VA
    J Pediatr; 2005 Sep; 147(3):327-31. PubMed ID: 16182670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Very high-dose ergocalciferol is effective for correcting vitamin D deficiency in children and young adults with cystic fibrosis.
    Boas SR; Hageman JR; Ho LT; Liveris M
    J Cyst Fibros; 2009 Jul; 8(4):270-2. PubMed ID: 19447079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum immunoreactive pancreatic lipase and cationic trypsinogen for the assessment of exocrine pancreatic function in older patients with cystic fibrosis.
    Cleghorn G; Benjamin L; Corey M; Forstner G; Dati F; Durie P
    Pediatrics; 1986 Mar; 77(3):301-6. PubMed ID: 3951910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.